KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2019 - 2025)

Rigel Pharmaceuticals (RIGL) has 9 years of Interest Coverage Ratio data on record, last reported at 13.64 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 60.08% year-over-year to 13.64; the TTM value through Dec 2025 reached 17.14, up 460.99%, while the annual FY2025 figure was 17.14, 460.99% up from the prior year.
  • Interest Coverage Ratio reached 13.64 in Q4 2025 per RIGL's latest filing, down from 15.01 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 86.09 in Q1 2021 and bottomed at 22.79 in Q2 2022.
  • Average Interest Coverage Ratio over 5 years is 2.37, with a median of 1.07 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: crashed 207.17% in 2022, then surged 14700.2% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 16.49 in 2021, then soared by 111.39% to 1.88 in 2022, then plummeted by 45.11% to 1.03 in 2023, then skyrocketed by 726.35% to 8.52 in 2024, then skyrocketed by 60.08% to 13.64 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 13.64 in Q4 2025, 15.01 in Q3 2025, and 32.61 in Q2 2025.